Stanford Biosecurity Speakers & Advisors
George W. Anderson, Jr., PhD, RBP
Chair of the Institutional Biosafety Committee at Lawrence Livermore National Labs
Ellen Jo Baron, PhD
Professor Emerita, Department of Pathology, Stanford University School of Medicine. She was formerly Director of the Clinical Microbiology and Clinical Virology Laboratories at Stanford University Medical Center.
Rear Admiral Kenneth Bernard MD, USPHS (Ret)
Former Special Assistant to the President Bush for Biodefense
Elizabeth (Beth) Cameron, Ph.D
Vice President for global biological policy at the NTI; Former Director of Countering Biological Threats on the National Security Council at The White House.
Ken Coleman, PhD, MBA
Former Senior Fellow for the Chemical and Biological Weapons Nonproliferation Program (CBWNP) of the James Martin Center for Nonproliferation Studies at the Monterey Institute of International Studies (MIIS).
Drew Endy, PhD
Leader in the field of Synthetic Biology, faculty at the BioEngineering Department at Stanford
Nima Farzan, MBA
Former Chief Executive Officer & President of PaxVax
David Fidler, JD, M.Phil, B.C.L
Professor of Law at the Indiana University and author of “BioSecurity in the Global Age.”
Milana Boukhman Trounce, MD MBA
Clinical Professor and Director of BioSecurity and Pandemic Resilience, Department of Emergency Medicine, Stanford Medical School
President and CEO of In-Q-Tel, the independent strategic investment firm that identifies innovative technologies to support the missions of the Central Intelligence Agency and the broader Intelligence Community.
Hank Greely, JD
Director, Center for Law and the Biosciences at the Stanford Law School; Professor (by courtesy) of Genetics, Stanford School of Medicine; Chair, Steering Committee of the Center for Biomedical Ethics.
Futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science.
Michael J. Hopmeier
President, Unconventional Concepts, Inc, and advisor to the World Health Organization, US Surgeon General, DARPA, US Army Medical Research and Materiel Command and other organizations.
Paul Jackson, PhD
Microbiology and microbial forensics expert, former head of the Biosciences and Biotechnology Division at the Lawrence Livermore National Labs.
Robert Kadlec, MD MS
Assistant Secretary of Health and Human Services (Preparedness and Response), US Department of Health and Human Services
Senior Policy Fellow at the Center for Global Development.
Jeremy Konyndyk is a Senior Policy Fellow at the Center for Global Development. His research focuses on humanitarian response, USAID policy reform, and global outbreak preparedness.
Akhila Kosaraju, MD
CEO and President of Phare Bio
Colonel Randall J. Larsen, USAF (Ret).
Senior Fellow at the Homeland Security Policy Institute at George Washington University, former CEO of the Weapons of Mass Destruction (WMD) Center, a non-for-profit organization he founded along with former Senators Bob Graham (D-FL) and Jim Talent (R-MO).
Wouter Latour, MD, MBA
Chief Executive Officer and Director of Vaxart
Chuck Ludlam, JD (retired)
Former Senior Counsel with Senator Joseph Lieberman, former Vice President for Government relations of the Biotechnology Industry Organization (BIO).
Chairman and Co-Founder of Q-Global.
Jon C. Mirsalis, PhD
Managing Director, Biosciences Division at SRI International
Tara O’Toole, MD, MPH
Executive Vice President at In-Q-Tel, former Under Secretary of the Science and Technology Division of the Department of Homeland Security
Condoleezza Rice, PhD
American scientist, diplomat, professor. Former US Secretary of State.
Mark Smolinski, MD, MPH
Director of Global Threats, Skoll Foundation.
Megan J. Palmer, PhD
Senior Scholar at the Center for International Security and Cooperation (CISAC), Stanford University.
Erica Pan, MD, MPH, FAAP
Deputy Health Officer and the Director of the Division of Communicable Disease Control & Prevention in the Alameda County Public Health Department.
George Poste, PhD
Chief Scientist, Complex Adaptive Systems Initiative (CASI), and Del E. Webb Professor of Health Innovation at Arizona State University (ASU).
Patrick J. Scannon, M.D., Ph.D.
Founder and former CEO of Xoma.